Stay updated with breaking news from Sciences Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SELLAS Life Sciences Group, Inc. (SLS) announced Thursday positive topline data for the patient group with relapsed/refractory (r/r) lymphomas from the Phase 1 dose-escalation trial of its CDK9 inhibitor, SLS009 (GFH009).
Octopus AIM VCT 2 plc Portfolio Update The investment portfolio of Octopus AIM VCT 2 plc as at 13 September 2023 is as follows : Portfolio companySectorBook cost Movement in valuation Fair...
An independent data monitoring committee has recommended that the phase 3 REGAL trial evaluating galinpepimut-S in patients with acute myeloid leukemia should continue without modifications.
An executive in an Orchard Park technology firm who did not pay more than $1.1 million in employment taxes has pleaded guilty to a federal tax charge, U.S. Attorney Trini
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...